Related references
Note: Only part of the references are listed.Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis
Mei Zong et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra
Bernd Raffeiner et al.
JOINT BONE SPINE (2011)
Do studies in humans better depict Th17 cells?
Francesco Annunziato et al.
BLOOD (2009)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
Marco Gattorno et al.
ARTHRITIS AND RHEUMATISM (2008)
Interrelation of inflammation and APP in sIBM:: IL-1β induces accumulation of β-amyloid in skeletal muscle
Jens Schmidt et al.
BRAIN (2008)
Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: A case report
Antonio Furlan et al.
JOINT BONE SPINE (2008)
Tumor necrosis factor as a therapeutic target of rheumatologic disease
Christoph Ackermann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies
Cecilia Grundtman et al.
ARTHRITIS AND RHEUMATISM (2007)
Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis
C. Dorph et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients
P. Efthimiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis
AME Sallum et al.
AUTOIMMUNITY REVIEWS (2006)
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies
CV Oddis et al.
ARTHRITIS AND RHEUMATISM (2005)
Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist
T Alexander et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
International consensus on preliminary definitions of improvement in adult and juvenile myositis
LG Rider et al.
ARTHRITIS AND RHEUMATISM (2004)
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
DA Isenberg et al.
RHEUMATOLOGY (2004)
Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: Long-term follow-up
GJD Hengstman et al.
EUROPEAN NEUROLOGY (2004)
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome
PN Hawkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The expression of adhesion molecules in muscle biopsies: the LFA-1/VLA-4 ratio in polymyositis
B Lindvall et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: Preliminary observations
GJD Hengstman et al.
EUROPEAN NEUROLOGY (2003)
Interleukin-1α expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients -: Important pathogenic features independent of inflammatory cell clusters in muscle tissue
P Englund et al.
ARTHRITIS AND RHEUMATISM (2002)
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies
FW Miller et al.
RHEUMATOLOGY (2001)
Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis
K Son et al.
INTERNAL MEDICINE (2000)
Share Paper
